BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradfute SB, Swanson PE, Smith MA, Watanabe E, McDunn JE, Hotchkiss RS, Bavari S. Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis. J Immunol. 2010;184:327-335. [PMID: 20028660 DOI: 10.4049/jimmunol.0901231] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Mahmud-Al-Rafat A, Majumder A, Taufiqur Rahman KM, Mahedi Hasan AM, Didarul Islam KM, Taylor-Robinson AW, Billah MM. Decoding the enigma of antiviral crisis: Does one target molecule regulate all? Cytokine 2019;115:13-23. [PMID: 30616034 DOI: 10.1016/j.cyto.2018.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
2 Monette A, Mouland AJ. T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders. Int Rev Cell Mol Biol 2019;342:175-263. [PMID: 30635091 DOI: 10.1016/bs.ircmb.2018.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
4 Rubio N, Sanz-Rodriguez F. Overexpression of caspase 1 in apoptosis-resistant astrocytes infected with the BeAn Theiler's virus. J Neurovirol 2016;22:316-26. [PMID: 26567013 DOI: 10.1007/s13365-015-0400-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 2011;17:964-76. [PMID: 21722250 DOI: 10.1111/j.1469-0691.2011.03535.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 71] [Article Influence: 8.3] [Reference Citation Analysis]
6 Rubio N, Garcia-segura LM, Arevalo M. Survivin prevents apoptosis by binding to caspase-3 in astrocytes infected with the BeAn strain of Theiler’s murine encephalomyelitis virus. J Neurovirol 2012;18:354-63. [DOI: 10.1007/s13365-012-0112-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
7 Caballero IS, Honko AN, Gire SK, Winnicki SM, Melé M, Gerhardinger C, Lin AE, Rinn JL, Sabeti PC, Hensley LE, Connor JH. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genomics 2016;17:707. [PMID: 27595844 DOI: 10.1186/s12864-016-3060-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
8 Bradfute SB, Bavari S. Correlates of immunity to filovirus infection. Viruses 2011;3:982-1000. [PMID: 21994766 DOI: 10.3390/v3070982] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
9 Smither SJ, Nelson M, Eastaugh L, Nunez A, Salguero FJ, Lever MS. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit. J Infect Dis 2015;212 Suppl 2:S336-45. [PMID: 26209682 DOI: 10.1093/infdis/jiv371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
10 Wolf K, Beimforde N, Falzarano D, Feldmann H, Schnittler HJ. The Ebola virus soluble glycoprotein (sGP) does not affect lymphocyte apoptosis and adhesion to activated endothelium. J Infect Dis 2011;204 Suppl 3:S947-52. [PMID: 21987774 DOI: 10.1093/infdis/jir322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 de La Vega MA, Wong G, Kobinger GP, Qiu X. The multiple roles of sGP in Ebola pathogenesis. Viral Immunol 2015;28:3-9. [PMID: 25354393 DOI: 10.1089/vim.2014.0068] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
12 McElroy AK, Mühlberger E, Muñoz-Fontela C. Immune barriers of Ebola virus infection. Curr Opin Virol 2018;28:152-60. [PMID: 29452995 DOI: 10.1016/j.coviro.2018.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
13 Wallace HL, Wang L, Gardner CL, Corkum CP, Grant MD, Hirasawa K, Russell RS. Crosstalk Between Pyroptosis and Apoptosis in Hepatitis C Virus-induced Cell Death. Front Immunol 2022;13:788138. [DOI: 10.3389/fimmu.2022.788138] [Reference Citation Analysis]
14 Bradfute SB, Warfield KL, Bray M. Mouse models for filovirus infections. Viruses 2012;4:1477-508. [PMID: 23170168 DOI: 10.3390/v4091477] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
15 Smith JR, Todd S, Ashander LM, Charitou T, Ma Y, Yeh S, Crozier I, Michael MZ, Appukuttan B, Williams KA, Lynn DJ, Marsh GA. Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye. Transl Vis Sci Technol 2017;6:12. [PMID: 28721309 DOI: 10.1167/tvst.6.4.12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
16 Pleet ML, DeMarino C, Lepene B, Aman MJ, Kashanchi F. The Role of Exosomal VP40 in Ebola Virus Disease. DNA Cell Biol 2017;36:243-8. [PMID: 28177658 DOI: 10.1089/dna.2017.3639] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
17 Diallo I, Ho J, Laffont B, Laugier J, Benmoussa A, Lambert M, Husseini Z, Soule G, Kozak R, Kobinger GP, Provost P. Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus. Int J Mol Sci 2021;22:3792. [PMID: 33917562 DOI: 10.3390/ijms22073792] [Reference Citation Analysis]
18 Olejnik J, Hume AJ, Leung DW, Amarasinghe GK, Basler CF, Mühlberger E. Filovirus Strategies to Escape Antiviral Responses. Curr Top Microbiol Immunol 2017;411:293-322. [PMID: 28685291 DOI: 10.1007/82_2017_13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Vine V, Scott DP, Feldmann H. Ebolavirus: An Overview of Molecular and Clinical Pathogenesis. Methods Mol Biol 2017;1628:39-50. [PMID: 28573609 DOI: 10.1007/978-1-4939-7116-9_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 McElroy AK, Akondy RS, Mcllwain DR, Chen H, Bjornson-Hooper Z, Mukherjee N, Mehta AK, Nolan G, Nichol ST, Spiropoulou CF. Immunologic timeline of Ebola virus disease and recovery in humans. JCI Insight 2020;5:137260. [PMID: 32434986 DOI: 10.1172/jci.insight.137260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
21 Shurtleff AC, Bavari S. Animal models for ebolavirus countermeasures discovery: what defines a useful model? Expert Opin Drug Discov 2015;10:685-702. [PMID: 26004783 DOI: 10.1517/17460441.2015.1035252] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
22 Spengler JR, Saturday G, Lavender KJ, Martellaro C, Keck JG, Nichol ST, Spiropoulou CF, Feldmann H, Prescott J. Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver. J Infect Dis 2017;217:58-63. [PMID: 29087482 DOI: 10.1093/infdis/jix562] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
23 Pleet ML, Mathiesen A, DeMarino C, Akpamagbo YA, Barclay RA, Schwab A, Iordanskiy S, Sampey GC, Lepene B, Nekhai S, Aman MJ, Kashanchi F. Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction. Front Microbiol 2016;7:1765. [PMID: 27872619 DOI: 10.3389/fmicb.2016.01765] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
24 Rasmussen AL. Host Factors Involved in Ebola Virus Replication. In: Tripp RA, Tompkins SM, editors. Roles of Host Gene and Non-coding RNA Expression in Virus Infection. Cham: Springer International Publishing; 2018. pp. 113-50. [DOI: 10.1007/82_2017_27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Konduru K, Bradfute SB, Jacques J, Manangeeswaran M, Nakamura S, Morshed S, Wood SC, Bavari S, Kaplan GG. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine 2011;29:2968-77. [PMID: 21329775 DOI: 10.1016/j.vaccine.2011.01.113] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
26 McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Ströher U, Damon I, Nichol ST, Spiropoulou CF, Ahmed R. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015;112:4719-24. [PMID: 25775592 DOI: 10.1073/pnas.1502619112] [Cited by in Crossref: 202] [Cited by in F6Publishing: 182] [Article Influence: 28.9] [Reference Citation Analysis]
27 Olejnik J, Ryabchikova E, Corley RB, Mühlberger E. Intracellular events and cell fate in filovirus infection. Viruses 2011;3:1501-31. [PMID: 21927676 DOI: 10.3390/v3081501] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
28 Chiappelli F, Bakhordarian A, Thames AD, Du AM, Jan AL, Nahcivan M, Nguyen MT, Sama N, Manfrini E, Piva F, Rocha RM, Maida CA. Ebola: translational science considerations. J Transl Med 2015;13:11. [PMID: 25592846 DOI: 10.1186/s12967-014-0362-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
29 Reed C, Steele KE, Honko A, Shamblin J, Hensley LE, Smith DR. Ultrastructural study of Rift Valley fever virus in the mouse model. Virology 2012;431:58-70. [PMID: 22687428 DOI: 10.1016/j.virol.2012.05.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
30 Yamaoka S, Banadyga L, Bray M, Ebihara H. Small Animal Models for Studying Filovirus Pathogenesis. Curr Top Microbiol Immunol 2017;411:195-227. [PMID: 28653189 DOI: 10.1007/82_2017_9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Zhou X, Jiang W, Liu Z, Liu S, Liang X. Virus Infection and Death Receptor-Mediated Apoptosis. Viruses 2017;9:E316. [PMID: 29077026 DOI: 10.3390/v9110316] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 12.4] [Reference Citation Analysis]
32 Ebihara H, Zivcec M, Gardner D, Falzarano D, LaCasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y, Feldmann H. A Syrian golden hamster model recapitulating ebola hemorrhagic fever. J Infect Dis 2013;207:306-18. [PMID: 23045629 DOI: 10.1093/infdis/jis626] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 8.0] [Reference Citation Analysis]
33 Pleet ML, Erickson J, DeMarino C, Barclay RA, Cowen M, Lepene B, Liang J, Kuhn JH, Prugar L, Stonier SW, Dye JM, Zhou W, Liotta LA, Aman MJ, Kashanchi F. Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles. J Infect Dis 2018;218:S365-87. [PMID: 30169850 DOI: 10.1093/infdis/jiy472] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
34 Brannan JM, Froude JW, Prugar LI, Bakken RR, Zak SE, Daye SP, Wilhelmsen CE, Dye JM. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease. J Infect Dis 2015;212 Suppl 2:S282-94. [PMID: 25943199 DOI: 10.1093/infdis/jiv215] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
35 Siragam V, Wong G, Qiu XG. Animal models for filovirus infections. Zool Res 2018;39:15-24. [PMID: 29511141 DOI: 10.24272/j.issn.2095-8137.2017.053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
36 Lai KY, Ng WY, Cheng FF. Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty 2014;3:43. [PMID: 25699183 DOI: 10.1186/2049-9957-3-43] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
37 Rivera A, Messaoudi I. Molecular mechanisms of Ebola pathogenesis. J Leukoc Biol 2016;100:889-904. [PMID: 27587404 DOI: 10.1189/jlb.4RI0316-099RR] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
38 Makris S, de Winde CM, Horsnell HL, Cantoral-rebordinos JA, Finlay RE, Acton SE. Immune function and dysfunction are determined by lymphoid tissue efficacy. Disease Models & Mechanisms 2022;15:dmm049256. [DOI: 10.1242/dmm.049256] [Reference Citation Analysis]
39 Atkins C, Miao J, Kalveram B, Juelich T, Smith JK, Perez D, Zhang L, Westover JLB, Van Wettere AJ, Gowen BB, Wang Z, Freiberg AN. Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters. J Infect Dis 2018;218:S438-47. [PMID: 30192975 DOI: 10.1093/infdis/jiy457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Olejnik J, Alonso J, Schmidt KM, Yan Z, Wang W, Marzi A, Ebihara H, Yang J, Patterson JL, Ryabchikova E, Mühlberger E. Ebola virus does not block apoptotic signaling pathways. J Virol 2013;87:5384-96. [PMID: 23468487 DOI: 10.1128/JVI.01461-12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
41 Schmidt KM, Schümann M, Olejnik J, Krähling V, Mühlberger E. Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis 2011;204 Suppl 3:S861-70. [PMID: 21987762 DOI: 10.1093/infdis/jir308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
42 Spengler JR, Welch SR, Genzer SC, Coleman-McCray J, Harmon JR, Nichol ST, Spiropoulou CF. Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response. Emerg Infect Dis 2019;25:1238-40. [PMID: 30900978 DOI: 10.3201/eid2506.181928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, Kawaoka Y, Feldmann H, Katze MG. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 2011;85:9060-8. [PMID: 21734050 DOI: 10.1128/JVI.00659-11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
44 Messaoudi I, Amarasinghe GK, Basler CF. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat Rev Microbiol 2015;13:663-76. [PMID: 26439085 DOI: 10.1038/nrmicro3524] [Cited by in Crossref: 140] [Cited by in F6Publishing: 125] [Article Influence: 20.0] [Reference Citation Analysis]
45 Warfield KL, Olinger GG. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever. J Biomed Biotechnol 2011;2011:984241. [PMID: 22253531 DOI: 10.1155/2011/984241] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
46 Kuypers FA. Hyperinflammation, apoptosis, and organ damage. Exp Biol Med (Maywood) 2022;:15353702221090454. [PMID: 35475359 DOI: 10.1177/15353702221090454] [Reference Citation Analysis]